0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enzyme Immunoassay Reagents and Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-25Y17175
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Enzyme Immunoassay Reagents and Devices Market Research Report 2024
BUY CHAPTERS

Global Enzyme Immunoassay Reagents and Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-25Y17175
Report
November 2025
Pages:155
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Enzyme Immunoassay Reagents and Devices Market

The global Enzyme Immunoassay Reagents and Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Medical Diagnosis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Enzyme Immunoassay Reagents and Devices leading manufacturers including Thermo Fisher Scientific, BD, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, Roche, Hologic, Abbott, Merck KGaA, bioMerieux, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Enzyme Immunoassay Reagents and Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Enzyme Immunoassay Reagents and Devices Market Report

Report Metric Details
Report Name Enzyme Immunoassay Reagents and Devices Market
Segment by Type
  • Direct ELISA
  • Indirect ELISA
  • Competition ELISA
Segment by Application
  • Medical Diagnosis
  • Biomedical Research
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, BD, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, Roche, Hologic, Abbott, Merck KGaA, bioMerieux, Promega, Siemens Healthcare, Danaher, Sartorius, DiaSorin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Enzyme Immunoassay Reagents and Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Enzyme Immunoassay Reagents and Devices Market report?

Ans: The main players in the Enzyme Immunoassay Reagents and Devices Market are Thermo Fisher Scientific, BD, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, Roche, Hologic, Abbott, Merck KGaA, bioMerieux, Promega, Siemens Healthcare, Danaher, Sartorius, DiaSorin

What are the Application segmentation covered in the Enzyme Immunoassay Reagents and Devices Market report?

Ans: The Applications covered in the Enzyme Immunoassay Reagents and Devices Market report are Medical Diagnosis, Biomedical Research, Other

What are the Type segmentation covered in the Enzyme Immunoassay Reagents and Devices Market report?

Ans: The Types covered in the Enzyme Immunoassay Reagents and Devices Market report are Direct ELISA, Indirect ELISA, Competition ELISA

1 Study Coverage
1.1 Introduction to Enzyme Immunoassay Reagents and Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Enzyme Immunoassay Reagents and Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Direct ELISA
1.2.3 Indirect ELISA
1.2.4 Competition ELISA
1.3 Market Segmentation by Application
1.3.1 Global Enzyme Immunoassay Reagents and Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Diagnosis
1.3.3 Biomedical Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Enzyme Immunoassay Reagents and Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Enzyme Immunoassay Reagents and Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Enzyme Immunoassay Reagents and Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Enzyme Immunoassay Reagents and Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Enzyme Immunoassay Reagents and Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Enzyme Immunoassay Reagents and Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Direct ELISA Market Size by Manufacturers
3.5.2 Indirect ELISA Market Size by Manufacturers
3.5.3 Competition ELISA Market Size by Manufacturers
3.6 Global Enzyme Immunoassay Reagents and Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Enzyme Immunoassay Reagents and Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Enzyme Immunoassay Reagents and Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Enzyme Immunoassay Reagents and Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Enzyme Immunoassay Reagents and Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Enzyme Immunoassay Reagents and Devices Sales and Revenue by Type (2020-2031)
6.4 North America Enzyme Immunoassay Reagents and Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Enzyme Immunoassay Reagents and Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Enzyme Immunoassay Reagents and Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Enzyme Immunoassay Reagents and Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Enzyme Immunoassay Reagents and Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Enzyme Immunoassay Reagents and Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Enzyme Immunoassay Reagents and Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Enzyme Immunoassay Reagents and Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Enzyme Immunoassay Reagents and Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Enzyme Immunoassay Reagents and Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Enzyme Immunoassay Reagents and Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Enzyme Immunoassay Reagents and Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.1.4 Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices Sales by Product in 2024
11.1.6 Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices Sales by Application in 2024
11.1.7 Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices Sales by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 BD
11.2.1 BD Corporation Information
11.2.2 BD Business Overview
11.2.3 BD Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.2.4 BD Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 BD Enzyme Immunoassay Reagents and Devices Sales by Product in 2024
11.2.6 BD Enzyme Immunoassay Reagents and Devices Sales by Application in 2024
11.2.7 BD Enzyme Immunoassay Reagents and Devices Sales by Geographic Area in 2024
11.2.8 BD Enzyme Immunoassay Reagents and Devices SWOT Analysis
11.2.9 BD Recent Developments
11.3 QIAGEN
11.3.1 QIAGEN Corporation Information
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.3.4 QIAGEN Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 QIAGEN Enzyme Immunoassay Reagents and Devices Sales by Product in 2024
11.3.6 QIAGEN Enzyme Immunoassay Reagents and Devices Sales by Application in 2024
11.3.7 QIAGEN Enzyme Immunoassay Reagents and Devices Sales by Geographic Area in 2024
11.3.8 QIAGEN Enzyme Immunoassay Reagents and Devices SWOT Analysis
11.3.9 QIAGEN Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Corporation Information
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.4.4 Agilent Technologies Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Agilent Technologies Enzyme Immunoassay Reagents and Devices Sales by Product in 2024
11.4.6 Agilent Technologies Enzyme Immunoassay Reagents and Devices Sales by Application in 2024
11.4.7 Agilent Technologies Enzyme Immunoassay Reagents and Devices Sales by Geographic Area in 2024
11.4.8 Agilent Technologies Enzyme Immunoassay Reagents and Devices SWOT Analysis
11.4.9 Agilent Technologies Recent Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Corporation Information
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.5.4 Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices Sales by Product in 2024
11.5.6 Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices Sales by Application in 2024
11.5.7 Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices Sales by Geographic Area in 2024
11.5.8 Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices SWOT Analysis
11.5.9 Bio-Rad Laboratories Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Business Overview
11.6.3 Roche Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.6.4 Roche Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Roche Recent Developments
11.7 Hologic
11.7.1 Hologic Corporation Information
11.7.2 Hologic Business Overview
11.7.3 Hologic Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.7.4 Hologic Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hologic Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Business Overview
11.8.3 Abbott Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.8.4 Abbott Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Corporation Information
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.9.4 Merck KGaA Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Merck KGaA Recent Developments
11.10 bioMerieux
11.10.1 bioMerieux Corporation Information
11.10.2 bioMerieux Business Overview
11.10.3 bioMerieux Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.10.4 bioMerieux Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 bioMerieux Recent Developments
11.11 Promega
11.11.1 Promega Corporation Information
11.11.2 Promega Business Overview
11.11.3 Promega Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.11.4 Promega Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Promega Recent Developments
11.12 Siemens Healthcare
11.12.1 Siemens Healthcare Corporation Information
11.12.2 Siemens Healthcare Business Overview
11.12.3 Siemens Healthcare Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.12.4 Siemens Healthcare Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Siemens Healthcare Recent Developments
11.13 Danaher
11.13.1 Danaher Corporation Information
11.13.2 Danaher Business Overview
11.13.3 Danaher Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.13.4 Danaher Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Danaher Recent Developments
11.14 Sartorius
11.14.1 Sartorius Corporation Information
11.14.2 Sartorius Business Overview
11.14.3 Sartorius Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.14.4 Sartorius Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Sartorius Recent Developments
11.15 DiaSorin
11.15.1 DiaSorin Corporation Information
11.15.2 DiaSorin Business Overview
11.15.3 DiaSorin Enzyme Immunoassay Reagents and Devices Product Models, Descriptions and Specifications
11.15.4 DiaSorin Enzyme Immunoassay Reagents and Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 DiaSorin Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Enzyme Immunoassay Reagents and Devices Industry Chain
12.2 Enzyme Immunoassay Reagents and Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Enzyme Immunoassay Reagents and Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Enzyme Immunoassay Reagents and Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Enzyme Immunoassay Reagents and Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Enzyme Immunoassay Reagents and Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Enzyme Immunoassay Reagents and Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Enzyme Immunoassay Reagents and Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Enzyme Immunoassay Reagents and Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Enzyme Immunoassay Reagents and Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Enzyme Immunoassay Reagents and Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Enzyme Immunoassay Reagents and Devices Sales by Region (2020-2025) & (K Units)
 Table 8. Global Enzyme Immunoassay Reagents and Devices Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Enzyme Immunoassay Reagents and Devices Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Enzyme Immunoassay Reagents and Devices Sales Share by Manufacturers (2020-2025)
 Table 12. Global Enzyme Immunoassay Reagents and Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Enzyme Immunoassay Reagents and Devices Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Enzyme Immunoassay Reagents and Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme Immunoassay Reagents and Devices as of 2024)
 Table 16. Global Enzyme Immunoassay Reagents and Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Enzyme Immunoassay Reagents and Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Enzyme Immunoassay Reagents and Devices Manufacturing Base and Headquarters
 Table 19. Global Enzyme Immunoassay Reagents and Devices Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Enzyme Immunoassay Reagents and Devices Sales by Type (2020-2025) & (K Units)
 Table 23. Global Enzyme Immunoassay Reagents and Devices Sales by Type (2026-2031) & (K Units)
 Table 24. Global Enzyme Immunoassay Reagents and Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Enzyme Immunoassay Reagents and Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Enzyme Immunoassay Reagents and Devices ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Enzyme Immunoassay Reagents and Devices Sales by Application (2020-2025) & (K Units)
 Table 29. Global Enzyme Immunoassay Reagents and Devices Sales by Application (2026-2031) & (K Units)
 Table 30. Enzyme Immunoassay Reagents and Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Enzyme Immunoassay Reagents and Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Enzyme Immunoassay Reagents and Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Enzyme Immunoassay Reagents and Devices ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Enzyme Immunoassay Reagents and Devices Growth Accelerators and Market Barriers
 Table 37. North America Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Enzyme Immunoassay Reagents and Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Enzyme Immunoassay Reagents and Devices Growth Accelerators and Market Barriers
 Table 40. Europe Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Enzyme Immunoassay Reagents and Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Enzyme Immunoassay Reagents and Devices Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Enzyme Immunoassay Reagents and Devices Investment Opportunities and Key Challenges
 Table 47. Central and South America Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Enzyme Immunoassay Reagents and Devices Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Enzyme Immunoassay Reagents and Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Thermo Fisher Scientific Corporation Information
 Table 51. Thermo Fisher Scientific Description and Major Businesses
 Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 53. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 57. Thermo Fisher Scientific Enzyme Immunoassay Reagents and Devices SWOT Analysis
 Table 58. Thermo Fisher Scientific Recent Developments
 Table 59. BD Corporation Information
 Table 60. BD Description and Major Businesses
 Table 61. BD Product Models, Descriptions and Specifications
 Table 62. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. BD Sales Value Proportion by Product in 2024
 Table 64. BD Sales Value Proportion by Application in 2024
 Table 65. BD Sales Value Proportion by Geographic Area in 2024
 Table 66. BD Enzyme Immunoassay Reagents and Devices SWOT Analysis
 Table 67. BD Recent Developments
 Table 68. QIAGEN Corporation Information
 Table 69. QIAGEN Description and Major Businesses
 Table 70. QIAGEN Product Models, Descriptions and Specifications
 Table 71. QIAGEN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. QIAGEN Sales Value Proportion by Product in 2024
 Table 73. QIAGEN Sales Value Proportion by Application in 2024
 Table 74. QIAGEN Sales Value Proportion by Geographic Area in 2024
 Table 75. QIAGEN Enzyme Immunoassay Reagents and Devices SWOT Analysis
 Table 76. QIAGEN Recent Developments
 Table 77. Agilent Technologies Corporation Information
 Table 78. Agilent Technologies Description and Major Businesses
 Table 79. Agilent Technologies Product Models, Descriptions and Specifications
 Table 80. Agilent Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Agilent Technologies Sales Value Proportion by Product in 2024
 Table 82. Agilent Technologies Sales Value Proportion by Application in 2024
 Table 83. Agilent Technologies Sales Value Proportion by Geographic Area in 2024
 Table 84. Agilent Technologies Enzyme Immunoassay Reagents and Devices SWOT Analysis
 Table 85. Agilent Technologies Recent Developments
 Table 86. Bio-Rad Laboratories Corporation Information
 Table 87. Bio-Rad Laboratories Description and Major Businesses
 Table 88. Bio-Rad Laboratories Product Models, Descriptions and Specifications
 Table 89. Bio-Rad Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Bio-Rad Laboratories Sales Value Proportion by Product in 2024
 Table 91. Bio-Rad Laboratories Sales Value Proportion by Application in 2024
 Table 92. Bio-Rad Laboratories Sales Value Proportion by Geographic Area in 2024
 Table 93. Bio-Rad Laboratories Enzyme Immunoassay Reagents and Devices SWOT Analysis
 Table 94. Bio-Rad Laboratories Recent Developments
 Table 95. Roche Corporation Information
 Table 96. Roche Description and Major Businesses
 Table 97. Roche Product Models, Descriptions and Specifications
 Table 98. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Roche Recent Developments
 Table 100. Hologic Corporation Information
 Table 101. Hologic Description and Major Businesses
 Table 102. Hologic Product Models, Descriptions and Specifications
 Table 103. Hologic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Hologic Recent Developments
 Table 105. Abbott Corporation Information
 Table 106. Abbott Description and Major Businesses
 Table 107. Abbott Product Models, Descriptions and Specifications
 Table 108. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Abbott Recent Developments
 Table 110. Merck KGaA Corporation Information
 Table 111. Merck KGaA Description and Major Businesses
 Table 112. Merck KGaA Product Models, Descriptions and Specifications
 Table 113. Merck KGaA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Merck KGaA Recent Developments
 Table 115. bioMerieux Corporation Information
 Table 116. bioMerieux Description and Major Businesses
 Table 117. bioMerieux Product Models, Descriptions and Specifications
 Table 118. bioMerieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. bioMerieux Recent Developments
 Table 120. Promega Corporation Information
 Table 121. Promega Description and Major Businesses
 Table 122. Promega Product Models, Descriptions and Specifications
 Table 123. Promega Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Promega Recent Developments
 Table 125. Siemens Healthcare Corporation Information
 Table 126. Siemens Healthcare Description and Major Businesses
 Table 127. Siemens Healthcare Product Models, Descriptions and Specifications
 Table 128. Siemens Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Siemens Healthcare Recent Developments
 Table 130. Danaher Corporation Information
 Table 131. Danaher Description and Major Businesses
 Table 132. Danaher Product Models, Descriptions and Specifications
 Table 133. Danaher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Danaher Recent Developments
 Table 135. Sartorius Corporation Information
 Table 136. Sartorius Description and Major Businesses
 Table 137. Sartorius Product Models, Descriptions and Specifications
 Table 138. Sartorius Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Sartorius Recent Developments
 Table 140. DiaSorin Corporation Information
 Table 141. DiaSorin Description and Major Businesses
 Table 142. DiaSorin Product Models, Descriptions and Specifications
 Table 143. DiaSorin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. DiaSorin Recent Developments
 Table 145. Key Raw Materials Distribution
 Table 146. Raw Materials Key Suppliers
 Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 148. Milestones in Production Technology Evolution
 Table 149. Distributors List
 Table 150. Market Trends and Market Evolution
 Table 151. Market Drivers and Opportunities
 Table 152. Market Challenges, Risks, and Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources


List of Figures
 Figure 1. Enzyme Immunoassay Reagents and Devices Product Picture
 Figure 2. Global Enzyme Immunoassay Reagents and Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Direct ELISA Product Picture
 Figure 4. Indirect ELISA Product Picture
 Figure 5. Competition ELISA Product Picture
 Figure 6. Global Enzyme Immunoassay Reagents and Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Medical Diagnosis
 Figure 8. Biomedical Research
 Figure 9. Other
 Figure 10. Enzyme Immunoassay Reagents and Devices Report Years Considered
 Figure 11. Global Enzyme Immunoassay Reagents and Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Enzyme Immunoassay Reagents and Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Enzyme Immunoassay Reagents and Devices Revenue Market Share by Region (2020-2031)
 Figure 15. Global Enzyme Immunoassay Reagents and Devices Sales (2020-2031) & (K Units)
 Figure 16. Global Enzyme Immunoassay Reagents and Devices Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Enzyme Immunoassay Reagents and Devices Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Enzyme Immunoassay Reagents and Devices Sales Volume Market Share in 2024
 Figure 19. Global Enzyme Immunoassay Reagents and Devices Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Direct ELISA Revenue Market Share by Manufacturer in 2024
 Figure 22. Indirect ELISA Revenue Market Share by Manufacturer in 2024
 Figure 23. Competition ELISA Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Enzyme Immunoassay Reagents and Devices Sales Market Share by Type (2020-2031)
 Figure 25. Global Enzyme Immunoassay Reagents and Devices Revenue Market Share by Type (2020-2031)
 Figure 26. Global Enzyme Immunoassay Reagents and Devices Sales Market Share by Application (2020-2031)
 Figure 27. Global Enzyme Immunoassay Reagents and Devices Revenue Market Share by Application (2020-2031)
 Figure 28. North America Enzyme Immunoassay Reagents and Devices Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Enzyme Immunoassay Reagents and Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) in 2024
 Figure 31. North America Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Enzyme Immunoassay Reagents and Devices Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Enzyme Immunoassay Reagents and Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 46. France Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Enzyme Immunoassay Reagents and Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 61. India Enzyme Immunoassay Reagents and Devices Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Enzyme Immunoassay Reagents and Devices Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Enzyme Immunoassay Reagents and Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Enzyme Immunoassay Reagents and Devices Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Enzyme Immunoassay Reagents and Devices Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Enzyme Immunoassay Reagents and Devices Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Enzyme Immunoassay Reagents and Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Enzyme Immunoassay Reagents and Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Enzyme Immunoassay Reagents and Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Enzyme Immunoassay Reagents and Devices Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Enzyme Immunoassay Reagents and Devices Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Enzyme Immunoassay Reagents and Devices Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Enzyme Immunoassay Reagents and Devices Revenue (2020-2025) & (US$ Million)
 Figure 82. Enzyme Immunoassay Reagents and Devices Industry Chain Mapping
 Figure 83. Regional Enzyme Immunoassay Reagents and Devices Manufacturing Base Distribution (%)
 Figure 84. Global Enzyme Immunoassay Reagents and Devices Production Market Share by Region (2020-2031)
 Figure 85. Enzyme Immunoassay Reagents and Devices Production Process
 Figure 86. Regional Enzyme Immunoassay Reagents and Devices Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS